Todd Pettingill
Corporate Officer/Principal presso OMNIAB, INC.
Profilo
Todd Pettingill is currently the Vice President of Business Development and Strategy at OmniAb Operations, Inc. and OmniAb, Inc. He previously worked as a Senior Manager of Corporate Development at Ligand Pharmaceuticals, Inc. Mr. Pettingill received his undergraduate degree from Brigham Young University and his MBA from UCLA Anderson School of Management.
Posizioni attive di Todd Pettingill
Società | Posizione | Inizio |
---|---|---|
OMNIAB, INC. | Corporate Officer/Principal | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Todd Pettingill
Società | Posizione | Fine |
---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Contatto Relazioni con gli Investitori | - |
Formazione di Todd Pettingill
Brigham Young University | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
OMNIAB, INC. | Commercial Services |
Aziende private | 1 |
---|---|
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Todd Pettingill